PAVmed, Inc. (PAVM)
1.18
-0.02
(-1.67%)
USD |
NASDAQ |
Nov 20, 16:00
1.18
0.00 (0.00%)
After-Hours: 20:00
PAVmed Enterprise Value : 2.336M for Nov. 19, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 19, 2026 | 2.336M |
| November 18, 2026 | 3.170M |
| November 17, 2026 | 4.489M |
| November 16, 2026 | 6.156M |
| November 13, 2026 | 5.322M |
| November 12, 2026 | 3.302M |
| November 11, 2026 | 5.149M |
| November 10, 2026 | 4.836M |
| November 09, 2026 | 5.322M |
| November 06, 2026 | 4.911M |
| November 05, 2026 | 4.767M |
| November 04, 2026 | 5.531M |
| November 03, 2026 | 6.642M |
| November 02, 2026 | 7.267M |
| October 30, 2026 | 7.545M |
| October 29, 2026 | 7.684M |
| October 28, 2026 | 8.448M |
| October 27, 2026 | 8.864M |
| October 26, 2026 | 9.698M |
| October 23, 2026 | 9.073M |
| October 22, 2026 | 8.240M |
| October 21, 2026 | 8.552M |
| October 20, 2026 | 9.490M |
| October 19, 2026 | 9.628M |
| October 16, 2026 | 10.74M |
| Date | Value |
|---|---|
| October 15, 2026 | 10.84M |
| October 14, 2026 | 9.906M |
| October 13, 2026 | 12.34M |
| October 12, 2026 | 12.68M |
| October 09, 2026 | 13.38M |
| October 08, 2026 | 12.68M |
| October 07, 2026 | 13.03M |
| October 06, 2026 | 12.58M |
| October 05, 2026 | 12.48M |
| October 02, 2026 | 13.93M |
| October 01, 2026 | 12.75M |
| September 30, 2026 | 19.63M |
| September 29, 2026 | 25.31M |
| September 28, 2026 | 25.19M |
| September 25, 2026 | 25.50M |
| September 24, 2026 | 25.72M |
| September 23, 2026 | 26.39M |
| September 22, 2026 | 27.61M |
| September 21, 2026 | 26.28M |
| September 18, 2026 | 26.22M |
| September 17, 2026 | 26.28M |
| September 16, 2026 | 25.97M |
| September 15, 2026 | 25.97M |
| September 14, 2026 | 28.92M |
| September 11, 2026 | 27.60M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Abbott Laboratories | 207.35B |
| AngioDynamics, Inc. | 433.25M |
| Alphatec Holdings, Inc. | 1.596B |
| AtriCure, Inc. | 2.665B |
| Baxter International, Inc. | 19.15B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -13.04M |
| Revenue (Quarterly) | 0.041M |
| Total Expenses (Quarterly) | 11.70M |
| EPS Diluted (Quarterly) | -1.770 |
| Gross Profit Margin (Quarterly) | -331.7% |
| Profit Margin (Quarterly) | -31.79K% |
| Earnings Yield | -799.3% |
| Normalized Earnings Yield | -789.70 |